Lixte Biotechnology Holdings, Inc.
2 clinical trials · Sponsor
◉ Watch Lixte Biotechnology Holdings, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) (NCT03886662) | Lixte Biotechnology Holdings, Inc. | 2019-04-01 |
Track Lixte Biotechnology Holdings, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.